1. OP0193 BIIB059, A HUMANIZED MONOCLONAL ANTIBODY TARGETING BDCA2 ON PLASMACYTOID DENDRITIC CELLS (PDC), SHOWS DOSE-RELATED EFFICACY IN THE PHASE 2 LILAC STUDY IN PATIENTS (PTS) WITH ACTIVE CUTANEOUS LUPUS ERYTHEMATOSUS (CLE). (2nd June 2020) Authors: Werth, V.; Furie, R.; Romero-Diaz, J.; Navarra, S.; Kalunian, K.; Van Vollenhoven, R.; Nyberg, F.; Kaffenberger, B.; Sheikh, S.; Radunovic, G.; Huang, X.; Carroll, H.; Gaudreault, F.; Meyers, A.; Barbey, C.; Musselli, C.; Franchimont, N. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Potential exposure to Australian bat lyssavirus is unlikely to prevent future bat handling among adults in South East Queensland. (8th December 2017) Authors: Young, M. K.; Banu, S.; McCall, B. J.; Vlack, S.; Carroll, H.; Bennett, S.; Davison, R.; Francis, D. Journal: Zoonoses and public health Issue: Volume 65:Number 1(2018) Page Start: e237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗